Status:
COMPLETED
Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty
Lead Sponsor:
Daniela Francescato Veiga
Conditions:
Plastic Surgery
Mammaplasty
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Setting: Translacional Surgery Graduation Program - Universidade Federal de São Paulo and Hospital das Clínicas Samuel Libânio - Universidade do Vale do Sapucaí. Background: Breast reduction is one of...
Eligibility Criteria
Inclusion
- 18 and 60 years of age
- body mass index (BMI) between 19 and 30 kg/m2
- breast hypertrophy according to the criteria of Sacchini et al. and Franco and Rebello
Exclusion
- patients who had previously undergone another surgical procedure of the breast
- patients who have been diagnosed with a breast pathology
- smokers
- patients who had a child or breastfed within the last year
- patients with uncontrolled comorbidities, such as arterial hypertension or diabetes
- use of immunosuppressants
- patients who had any infection during the follow-up period, requiring the use of antibiotics
- patients who present any adverse effects due to the antibiotics during the study
- patients who miss follow-up assessments
- patients who withdraw their consent at any time
Key Trial Info
Start Date :
August 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2024
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT04079686
Start Date
August 4 2019
End Date
October 28 2024
Last Update
February 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clinicas Samuel Libânio, Universidade do Vale do Sapucaí
Pouso Alegre, Minas Gerais, Brazil, 37550000